Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Short [paid promotional message] Interview with Roger

<< Previous

Bullboard Posts

Next >>

Comment by tdon1229on Aug 19, 2024 9:11am

209 Views

Post# 36185629

RE:RE:RE:RE:RE:RE:RE:RE:Short [paid promotional message] Interview with Roger

The previous pp remains open with only the first tranche having been obtained, but the company can't enroll and treat 10 more patients or open 5 more clinical sites w/o more money.

The warrants remain on track to expire at the end of this month rather than be exercised to replenish the company coffers.

No shelf offering has been approved, so debt financing doesn't appear to be on the near horizon.

I await Deus ex machina in the next act.

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles